A detailed history of Impact Capital Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Impact Capital Partners LLC holds 23,909 shares of ABT stock, worth $3.11 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
23,909
Previous 22,167 7.86%
Holding current value
$3.11 Million
Previous $3.01 Billion 6.22%
% of portfolio
0.96%
Previous 0.99%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025

BUY
$120.51 - $136.62 $209,928 - $237,992
1,742 Added 7.86%
23,909 $3.2 Billion
Q2 2025

Jul 18, 2025

BUY
$123.95 - $138.08 $44,250 - $49,294
357 Added 1.64%
22,167 $3.01 Billion
Q1 2025

Apr 11, 2025

BUY
$111.1 - $140.22 $91,768 - $115,821
826 Added 3.94%
21,810 $2.89 Billion
Q4 2024

Feb 10, 2025

BUY
$111.93 - $119.39 $2.35 Million - $2.51 Million
20,984 New
20,984 $2.37 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Impact Capital Partners LLC Portfolio

Follow Impact Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impact Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Impact Capital Partners LLC with notifications on news.